Moreover, PIMREG was verified to promote breast cancer (BRCA) aggressiveness through activation of the NF-κB pathway, suggesting that it may be a novel prognostic indicator for BBCA (Jiang et al., 2019; Sun et al., 2019). This evidence concerns the gene PIMREG and breast carcinoma.